Roche is one of the world’s leading healthcare companies and the top investor in pharmaceutical R&D. pRED (Roche Pharma Research & Early Development) is at the forefront of groundbreaking science with a rich portfolio of innovative therapies for patients. The failure rate in the early phase of drug development is high, and it requires a constant process of review and prioritization, as well as efficient collaboration across scientific expert teams with highly specialized skills.
Taking advantage of the cplace platform, Roche has established TIGER, an innovative project and portfolio management platform to master their highly dynamic drug discovery projects.
TIGER is the acronym for Transparency, Innovation, aGility, Empowerment, and Responsibility which perfectly describes the Roche culture based on trust, mutual empowerment, and collaboration.
TIGER provides individual discovery project teams with a broad spectrum of project management tools to efficiently manage their tasks and ensure delivery of key project milestones while offering a single data source for strategic portfolio management and decision making.
Our speakers will take you on a journey into the area of early pharmaceutical drug discovery.
Speakers:
